Drugs / pDC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02574377 | Sep 2015 → Sep 2021 | melanoma | Radboud University Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pDC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02574377 ↗ |
| Modality | Cell therapy | “intranodal injection with tumor peptide-loaded plasmacytoid dendritic cells” NCT02574377 ↗ |
| Route | Other | “intranodal injection with tumor peptide-loaded plasmacytoid dendritic cells” NCT02574377 ↗ |